Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
151.7 USD | -0.90% |
|
-3.97% | +57.35% |
26/06 | Monetary policy is getting even more confusing | ![]() |
26/06 | Citigroup Downgrades Sarepta Therapeutics to Neutral From Buy, Raises Price Target to $176 From $172 | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+57.35% | 14.34B | |
+16.61% | 122B | |
+17.75% | 112B | |
+18.84% | 25.91B | |
-24.11% | 19.33B | |
-17.75% | 16.17B | |
-18.47% | 15.6B | |
-47.75% | 14.65B | |
+5.62% | 14B | |
+125.88% | 11.29B |
- Stock Market
- Equities
- SRPT Stock
- News Sarepta Therapeutics, Inc.
- RBC Raises Price Target on Sarepta Therapeutics to $182 From $142, Maintains Sector Perform Rating